Transgene Biotek Ltd
BSE:526139
Transgene Biotek Ltd
BSE:526139
Price:
2.65
INR
7.72%
Market Closed
Market Cap:
₹200.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Transgene Biotek Ltd
BSE:526139
|
IN |
|
Cinderson Tech Suzhou Co Ltd
SSE:603344
|
CN |
|
C
|
Chrysos Corporation Ltd
OTC:CHRCF
|
AU |
|
D
|
Dogusan Boru Sanayi ve Ticaret AS
IST:DOGUB.E
|
TR |
|
Pharma Mar SA
MAD:PHM
|
ES |
|
Tata Communications Ltd
NSE:TATACOMM
|
IN |
|
A
|
Aishwarya Technologies and Telecom Ltd
BSE:532975
|
IN |
|
Kintavar Exploration Inc
XTSX:KTR
|
CA |
|
L
|
Leader Steel Holdings Berhad
KLSE:LSTEEL
|
MY |
|
Surgical Science Sweden AB
OTC:SUSRF
|
SE |
|
Bank Mayapada Internasional Tbk PT
IDX:MAYA
|
ID |
|
D
|
DaebongLS Co Ltd
KOSDAQ:078140
|
KR |
|
A
|
Amrest Holdings SE
WSE:EAT
|
ES |
|
CarGurus Inc
NASDAQ:CARG
|
US |
|
A
|
Albireo Pharma Inc
F:BDQM
|
US |
|
Ecofin US Renewables Infrastructure Trust PLC
LSE:RNEW
|
UK |
|
Humbl Inc
OTC:HMBL
|
US |
|
Evoke Pharma Inc
NASDAQ:EVOK
|
US |
|
P
|
Pluk Phak Praw Rak Mae PCL
SET:OKJ
|
TH |
|
T
|
Terranet AB
STO:TERRNT B
|
SE |
|
S
|
Salesforce Inc
XETRA:FOO
|
US |
|
S
|
Suprema HQ Inc
KOSDAQ:094840
|
KR |
|
ECD Automotive Design Inc
OTC:ECDA
|
US |
|
Open Lending Corp
NASDAQ:LPRO
|
US |
Multiples-Based Value
The Multiples-Based Value of one
TRABI
stock under the Base Case scenario is
hidden
INR.
Compared to the current market price of 2.65 INR,
Transgene Biotek Ltd
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TRABI Multiples-Based Value
LOCKED
Multiples Across Competitors
TRABI Competitors Multiples
Transgene Biotek Ltd Competitors
Transgene Biotek Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Transgene Biotek Ltd
BSE:526139
|
200.8m INR | 86.1 | -10.5 | -43.9 | -37.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
367.6B USD | 6 | 87.8 | 14.6 | 20.2 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.2B USD | 5.1 | 24.5 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.5B USD | 5.9 | 20.3 | 12.7 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.8B USD | 9.2 | 28 | 21 | 22 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD | 5.5 | 17.6 | 13 | 14.8 | |
| NL |
|
argenx SE
XBRU:ARGX
|
42.2B EUR | 11.8 | 38 | 41.1 | 41.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.1B AUD | 2.9 | 32.3 | 10.9 | 13.7 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
